Clinical Trial Update: A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers

View source ↗

Summary

The study evaluating Care4Today IBD for Crohn's disease was terminated, and no results have been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Crohn Disease | Status: TERMINATED